ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society. It covers original research on the molecular underpinnings of nerve function in organisms and animal models. The journal was established in September, 2009, ahead of the publication of the first issue in January 2010. The journal is one of the first journals of the American Chemical Society to be available in online-only format. The founding editor in chief is Craig W. Lindsley (Vanderbilt University). Notable authors include Joanna S. Fowler, Nora Volkow, and P. Jeffrey Conn. ACS Chemical Neuroscience publishes research letters, articles, and reviews that all are peer-reviewed. In addition, specially commissioned articles that describe journal content and advances in neuroscience are solicited from leaders in the field. Because of the online-only format, researchers can use functionalities available only on the web. The journal presents research dealing with diverse topics covering all areas of neuroscience such as neural development, plasticity, and degeneration; molecular and chemical analysis of neurotransmitters and receptors; design and development of pharmaceuticals
An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.
Aug 7, 2023
0
40
Researchers from the National Institutes of Natural Sciences and Nagoya City University have achieved a significant breakthrough by elucidating the structure of amyloid β (Aβ) bound to glycolipids on the surface of nerve ...
Aug 7, 2023
0
21
A definitive diagnosis of Alzheimer's disease (AD) was once only possible after someone had died, but recent biomarker studies have led to the development of imaging and spinal fluid tests for those still living. However, ...
Nov 9, 2022
0
53
A lipid found in the membranes of neurons may play a fundamental role in the development and progression of Alzheimer's disease, according to a study by Penn State College of Medicine researchers. Their findings, published ...
Aug 19, 2022
0
69
Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket, is thought to reduce ...
Aug 10, 2022
0
56
Cluster headaches, anxiety and depression can be debilitating for people living with these conditions. Psychedelic drugs have shown benefits as treatments for these conditions in clinical studies, but not for everyone. Now, ...
Jul 27, 2022
0
135
Copper exposure in the environment and the protein alpha-synuclein in the human brain could play an important role in the pathogenesis of Parkinson's disease. A team from Empa and the University of Limerick was able to show ...
Jul 7, 2022
0
99
A synchrotron-based study led by University of Saskatchewan (USask) researchers shows that the chemical form of mercury found in the brains of people who ate a lot of fish over a lifetime is completely different from the ...
May 16, 2022
0
57
Many brain diseases and disorders lead to neuroinflammation, a swelling of brain tissue that is increasingly recognized as one ofthe telltale signs and disease progression factors of Alzheimer's and Parkinson's disease. Neuroinflammation ...
Mar 31, 2022
0
34
A team of University of California, Irvine researchers has discovered a possible reason why L-dopa, the front-line drug for treating Parkinson's disease, loses efficacy and causes dyskinesia—involuntary, erratic muscle ...
Jan 20, 2022
0
254
